DHAI (DIH Holding US) Total Stockholders Equity: $-37.14 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is DIH Holding US Total Stockholders Equity?

DIH Holding US DHAI Total Stockholders Equity is $-37.14 Mil as of Mar. 2025.

DIH Holding US's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $-37.14 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. DIH Holding US's Book Value per Share for the quarter that ended in Mar. 2025 was $-21.97. The ratio of a company's debt over equity can be used to measure how leveraged this company is. DIH Holding US's Debt-to-Equity for the quarter that ended in Mar. 2025 was -0.40.

DIH Holding US  (OTCPK:DHAI) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

DIH Holding US's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(-37.135-0)/1.690
=-21.97

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

DIH Holding US's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(3.118 + 11.773) / -37.135
=-0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DIH Holding US Total Stockholders Equity Related Terms

DIH Holding US Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for DIH Holding US's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DIH Holding US Total Stockholders Equity Chart

DIH Holding US Annual Data
Trend Mar22 Mar23 Mar24 Mar25
Total Stockholders Equity
-26.42 -29.05 -32.55 -37.14

DIH Holding US Quarterly Data
Mar22 Dec22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only -32.55 -34.00 -34.40 -37.88 -37.14
What does a Total Stockholders Equity of $-37.14 Mil mean?
DIH Holding US (DHAI) has a Total Stockholders Equity of $-37.14 Mil as of Mar. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for DIH Holding US and its competitors.
Is DIH Holding US's Total Stockholders Equity too high?
DIH Holding US's current Total Stockholders Equity is $-37.14 Mil.
How does DIH Holding US's Total Stockholders Equity compare to ABT and SYK?
DIH Holding US's Total Stockholders Equity of $-37.14 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for DIH Holding US and its competitors. DIH Holding US's current Total Stockholders Equity is $-37.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DIH Holding US stock overvalued right now?
DIH Holding US (DHAI) has a current Total Stockholders Equity of $-37.14 Mil. The current Total Stockholders Equity is $-37.14 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For DIH Holding US (DHAI), the current Total Stockholders Equity is $-37.14 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DIH Holding US Business Description

Address 77 Accord Park Drive, Suite D-1, Norwell, MA, USA, 02061
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. It serves the healthcare systems, clinics, third-party healthcare providers, distributors and other institutions by providing a broad array of devices and services focused on the customer and patient recovery. Its key products are LokoMat, Erigo, Armeo, C-Mill and CAREN/Grail. Geographically, the company derives revenue from the EMEA, Americas, and Asia Pacific regions. The company generates revenue from the sale of medical rehabilitation devices and technology.